 |
 |
 |
 |
 |
| Chief Yasuyuki Hirashima, M.D., Ph.D. |
Senior Staff Munetaka Takekuma, M.D., Ph.D. |
Senior Staff Nobutaka Takahashi, M.D., Ph.D. |
Senior Staff Ayako Mochizuki, M.D. |
Senior Staff |
 |
 |
 |
 |
 |
| Senior Staff Nobuhiro Kado, M.D. |
Senior Staff Yuka Kasamatsu, M.D. |
Senior Staff Atsuko Kawamura, M.D. |
Resident Ryoken Nara, M.D. |
Resident Chika Eto, M.D. |
At the Division of Gynecology, all kinds of cancers in female genitals (female organs of reproduction) are diagnosed and treated. They include uterine cervical cancer, which is common among women from 20’s to 40’s, endometrial cancer, ovarian cancer, fallopian tube cancer, vaginal cancer, vulva cancer and choriocarcinoma. Basically, the therapies provided for gynecological cancers are either the choice from or the combination of three standard cancer treatments, i.e., surgery, radiation therapy and chemotherapy (drug treatment). At this division, cancer therapies other than radiation therapy are being provided
At the Division of Gynecology at the SCC, the number of gynecological cancer treatment cases is one of the biggest in Japan, which proves ample experiences for surgery, radiation therapy and chemotherapy in this field. The rich experiences ensure optimal choices of treatment, safe radical surgeries, well-suited chemotherapies and side effect controls, which are all being done on a daily basis. We have had very positive outcomes from these treatments.
Patients are treated with the “standard cancer treatments” indicated in the “EBM (evidence-based medicine)” including medical guide lines suggested by the Japan Society of Gynecologic Oncology and the NCCN (National Comprehensive Cancer Network) in the USA. They stand for the cancer treatments currently evaluated as the most effective.
Although what we basically offer is “standard cancer treatments” which are evaluated as the most effective at this moment, what our patients expect for their cancer treatments can vary depending on their senses of value and the circumstances surrounding them. For example, some of them may want us to “make it a priority to leave as many organs as possible, even if it means not to remove cancer completely,” or “give up any treatments which can be physically hard and let the life be quiet and relaxing” while others may want to “challenge any possible cancer treatments, even if the circumstances don’t look quite optimistic.” We always try to listen to each patient to see what she really feels about her cancer treatment, and discuss with all the staff involving not only the colleagues at this division but also the Radiation Therapy Center and the Division of Pathology until we reach the best therapy choice. In addition, we always try to offer the latest and the most accurate information so that our patients can make the best choices for “convincing cancer therapy.”
“Laparoscopic surgery” is a surgical procedure with a camera and surgical tools inserted through tiny holes made in the abdomen. It has been widely recognized as a far less invasive operation than conventional laparotomy. At this division, the surgeons with certified skills for laparoscopic surgery perform the procedure when indications are proven as applicable.
At most hospitals in general, they might give up surgeries when cancers are found as invading surrounding organs or metastatic. However, even for such cases, we look into the possibilities for extended operations in the first place including but not limited to the gynecological organs, always pursuing complete resections of all cancer lesions. When it is decided that an exte
nded operation is possible and there is an advantage for it, we will perform it collaborating with the surgeons from other relevant clinical departments.
We aim at development and establishment of new cancer therapies. Therefore, we participate in many clinical trials organized by such study groups as the Japan Clinical Oncology Group (JCOG), the Japan Gynecologic Oncology Group (JGOG) and the Kansai Clinical Oncology Group (KCOG), and make positive commitments for developing new cancer drugs.
We believe that it is one big mission for a cancer hospital to practice “a convincing cancer therapy in which a patient herself feels sufficient and content,” by employing various treatments skillfully. However, there can be side effects and complications for every cancer treatment, and it is necessary to discuss thoroughly with a patient before deciding on the therapeutic strategy. Therefore, we try to be fairly open with our patient about what is going on with the disease, as it is essential to share accurate information among the medical staff, the patient and her family for the discussion. A second opinion often helps a great deal in order to obtain “a convincing cancer therapy.” We would like the patients to feel free to be referred to the SCC from other medical institutions, or the other way around, for gaining second opinions.
gynecologic oncology
Certified Specialist and Supervisory Doctor, Representative, the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Commissioner, Committee Member for the Relevant Academic Meeting, Social Insurance Committee Member, Editorial Committee Member for the Guidelines, Editorial Committee Member for Revising the Uterine Corpus Cancer Therapy Guidelines, Subcommittee Member for Surgical Technique Trainings, Subcommittee Member for the Qualification Test for Specialist, the Japan Society of Gynecologic Oncology
Representative and Member of the Task Force on Cancer Treatment Covered by Health Insurance, the Japan Society of Clinical Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Japanese Cancer Association
The Japanese Society of Clinical Cytology
The Japanese Society of Medical Oncology
The Japanese Association for Metastasis Research
The Japan Society of Gynecological and Obstetrical Surgery
Commissioner and the Financial Committee Member, the Japanese Gynecologic Oncology Group (JGOG)
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
The Japan Organization of Hereditary Breast and Ovarian Cancer (JOHBOC)
Molecular-targeted Research Society in Japan Gynecologic Oncology
Clinical Professor, Hamamatsu University School of Medicine
gynecologic oncology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Councilor, Vice-chairman of the Editorial Committee for Revising the Uterine Corpus Cancer Therapy Guidelines, Editorial Committee Member for Revising the Uterine Cervical Cancer Therapy Guidelines, Editorial Committee Member for Revising the Ovarian Cancer Therapy Guidelines, Working Group Member per Organ for the Particle-beam Radiation Therapy Assessment, the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Cytodiagnosis Specialist and Commissioner for the Shizuoka Branch Office, the Japanese Society of Clinical Cytology
Working Group Committee Member for Revising the Guidelines for Proper Use of G-CSF, the Japan Society of Clinical Oncology
Working Group Committee Member for Revising the Cancer Immunotherapy Guidelines, The Japanese Society of Medical Oncology
The Japan Society of Gynecological and Obstetrical Surgery
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
Educational Seminar Lecturer, the Japan Organization of Hereditary Breast and Ovarian Cancer (JOHBOC)
Chairman of the Cervical Cancer Committee and Educational Board Member, the Japanese Gynecologic Oncology Group (JGOG)
Researcher, the (US) National Cancer Institute
Associate Editor, Gynecologic Oncology Research and Practice
Clinical Associate Professor, Hamamatsu University School of Medicine
gynecologic oncology
laparoscopic surgery
robot-assisted surgery
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Councilor, Working Group Member for Health Insurance Coverage of Endoscopic Surgery for Ovarian Cancer, the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Cytodiagnosis Specialist Certified by the Japanese Society of Clinical Cytology
Certified Doctor, the Japan Society for Sexually Transmitted Infections
Doctor with Certified Expertise, Councilor, Subcommittee Member for Expertise Qualification for Robotic Surgery, Editorial Committee Member for Revising the 2024 Guidelines of Gynecologic Endoscopy, the Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
Doctor with Expertise Certified by the Japan Society for Endoscopic Surgery
Specialist and Robo-Doc Pilot with Domestic Class-B License Certified by the Japan Robotic Surgery Society
Procter for Robot-Assisted Surgery in Gynecology Certified by the Japan Society for Endoscopic Surgery and the Japan Society for Gynecology Robotic Surgery
Specialist Certified by the Japan Society for Menopause and Women’s Health
Subcommittee Member for Medical Economy Assessment, Cross-sectional Working Group
Member for Indication Expansion of New MRD Test (Signatera) toward All Solid Tumors, the Japan Clinical Oncology Group (JCOG)
The Japan Society of Clinical Oncology
The Japanese Society of Medical Oncology
The Japan Society of Gynecological and Obstetrical Surgery
The Japanese Gynecologic Oncology Group (JGOG)
Researcher, the (US) National Cancer Institute
Clinical Associate Professor, Hamamatsu University School of Medicine
laparoscopic surgery
gynecologic oncology
robot-assisted surgery
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Specialist Certified by the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Doctor with Expertise Certified by the Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
Doctor with Expertise Certified by the Japan Society for Endoscopic Surgery
The Japan Society of Gynecologic Oncology
The Japan Robotic Surgery Society
The Japanese Gynecologic Oncology Group (JGOG)
The Japan Society of Clinical Oncology
gynecologic oncology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Editorial Committee Member for Revising the
Treatment Guidelines for Uterine Corpus Cancer, the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Japan Society of Clinical Oncology
The Japanese Cancer Association
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
Specialist Certified by the Japanese Society for Hereditary Tumors
Committee Member for Uterine Cervical Cancer, Qualification Committee Member for Clinical Trial and Ethical Regulations, the Japanese Gynecologic Oncology Group
gynecologic oncology
hereditary tumor
Specialist Certified by the Japan Society of Obstetrics and Gynecology
Specialist Certified by the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Clinical Geneticist Certified by the Japan Society of Human Genetics
International Exchange Committee Member, the Japanese Society for Genetic Counseling
The Japanese Gynecologic Oncology Group (JGOG)
The Japan Society of Clinical Oncology
The Japan Society of Gynecological and Obstetrical Surgery
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
The Japan Society for Endoscopic Surgery
The Japanese Society of Gynecological Cancer Screening
The Japanese Society of Clinical Cytology
Specialist Certified by the Japanese Society for Hereditary Tumors
Completed the Lymphedema Training Course Steps 1 and 2, the Life Planning Center
The Japanese HBOC Consortium
The Asian Society of Gynecologic Oncology (ASGO)The Japanese HBOC Consortium
The European Society of Gynecological Oncology (ESGO)
gynecologic oncology
Specialist Certified by the Japan Society of Obstetrics and Gynecology
Doctor for Radiogram Interpretation at the Breast Cancer Screening Certified by the Japan Central Organization on Quality Assurance of Breast Cancer Screening
Official ACLS (Advanced Cardiovascular Life Support) Instructor Certified by the Japan ACLS Association
Specialist Certified by the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Japanese Gynecologic Oncology Group (JGOG)
The Japan Society of Clinical Oncology
The Japan Society of Gynecological and Obstetrical Surgery
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
gynecology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Specialist Certified by the Japan Society of Gynecologic Oncology
The Japanese Gynecologic Oncology Group (JGOG)
The Japan Society of Clinical Oncology
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
The Japan Society of Perinatal and Neonatal Medicine
Accredited Instructor of the Neonatal Resuscitation Method for the Primary Course J, the Japan Society of Perinatal and Neonatal Medicine
Accredited Instructor for Basic J-MELS, the Japan Council for Implementation of Maternal Emergency Life Support System
gynecology
Specialist Certified by the Japan Society of Obstetrics and Gynecology
The Japan Society of Gynecologic Oncology
The Japanese Society of Medical Oncology
The Japan Society of Clinical Oncology
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
The Japan Society for Reproductive Medicine
The Japan Society of Human Genetics
The Japanese Society for Hereditary Tumors
The Japanese Gynecologic Oncology Group (JGOG)
gynecology
The Japan Society of Obstetrics and Gynecology
The Japan Society of Gynecologic Oncology
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
The Japan Placenta Association
